البرزدارو
دالبر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 18,260 2.99
Close Price: 18,260
Income Statement
AGM
Interim
2026/05/20 Fiscal Year 2025/12/2112 Month | 2025/02/17 Fiscal Year 2024/12/2012 Month | 2024/06/01 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 44.353 Trillion | 18.265 Trillion | 31.453 Trillion | |
Total Revenues | 44.353 Trillion | 18.265 Trillion | 31.453 Trillion | |
Cost of Goods Sold | 22.993 Trillion | 12.448 Trillion | 18.894 Trillion | |
Gross Profit | 21.36 Trillion | 5.817 Trillion | 12.56 Trillion | |
General & Administrative Expenses | 2.155 Trillion | 510.99 Billion | 464.962 Billion | |
Net Operating Income & Expenses | -316.595 Billion | -15.047 Billion | -61.969 Billion | |
Operating Profit (Loss) | 18.888 Trillion | 5.291 Trillion | 12.033 Trillion | |
Profit Before Tax | 14.961 Trillion | 2.832 Trillion | 8.536 Trillion | |
Tax | 2.645 Trillion | - | 1.208 Trillion | |
Net Profit (Loss) After Tax | 12.316 Trillion | 2.832 Trillion | 7.328 Trillion | |
Retained Earnings at Beginning of Period | 3.059 Trillion | 7.619 Trillion | 7.712 Trillion | |
Approved Dividends — Prior Year AGM | -1.08 Trillion | -4.75 Trillion | -4.211 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | -2.5 Trillion | -2.92 Trillion | |
Transfer from Other Equity Items | - | - | 2.374 Billion | |
Allocable Profit | 14.296 Trillion | 3.201 Trillion | 7.911 Trillion | |
Legal Reserve | 308.394 Billion | 141.606 Billion | 292 Billion | |
Approved Dividends — Current Year | 2.52 Trillion | 1.08 Trillion | 4.75 Trillion | |
Retained Earnings at End of Period | 11.467 Trillion | 1.979 Trillion | 2.869 Trillion |